The initiative's new leader says her first priority will be making connections with nearby institutions — and making 311 ...
A new biopharmaceutical company has formed after acquiring late-stage clinical drug assets from a slumping public company.
Gender-based civil society organisations (CSOs) have described the use of Technology Facilitated Gender-Based Violence (TFGBV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results